Moreover, the inhibitory effects of HIC1 on PCa cell proliferation and invasion, along with its potential to decrease castration resistance, suggest that HIC1 could be a promising therapeutic target for prostate cancer, opening up new avenues for clinical treatment. This evidence concerns the gene HIC1 and posterior cortical atrophy.